About the Residency Program

Sutter Health PGY2 Oncology Pharmacy Residency is an ASHP pre-accredited 12-month program builds upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training. Our program is designed to develop pharmacist practitioners with specialized knowledge, skills, and abilities in oncology. Our program offers residents with exposure to a variety of practice environments and experiences across the continuum of oncology care including the following settings within a not-for-profit health system:  

• Acute care hospital settings
• Ambulatory care services: 
  • Infusion Centers 
  • Pharmacotherapy clinics 
• Sutter Health System Office
• Research
• Specialty Pharmacy

Residents who successfully complete an Oncology PGY2 residency program will be proficient in diverse aspects of patient care, practice management, leadership, and education. They will be well prepared to provide high quality oncology patient care and pursue Board Certified Oncology Pharmacist (BCOP) certification.

Program Goals:

1. Equip residents with the advanced clinical skills and knowledge necessary to function independently and competently as oncology pharmacy practitioners, ensuring they can provide high-quality patient care.
2. Foster leadership abilities in residents, enabling them to effectively lead and manage oncology pharmacy services, contribute to multidisciplinary teams, and advocate for the profession.
3. Promote engagement in research and scholarly activities, empowering residents to contribute to the advancement of oncology pharmacy practice and improve patient outcomes through evidence-based research.